Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
AI has demonstrated considerable potential in diabetic foot (DF) management. AI-powered thermal imaging and predictive ...
3 天
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...
Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Lucentis is FDA-approved for the treatment of patients with wet age-related macular degeneration (AMD), macular edema ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果